Score Overview
Explore the 2021 public Archive ranking →
Where IDEXX Laboratories Inc has ranked, year by year
Showing 20 years ranking history by HDB Score.
Top 50 on HDB Score for 4 consecutive years, since 2018, through 2021.
- IDXX
2012: 3.6% · 2021: 0.5% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-14 | $ 509.56 | — |
1 Year2025-09-12 | $ 641.14 | -20.52% |
5 Years2021-09-14 | $ 661.39 | -22.96% |
10 Years2016-09-14 | $ 108.57 | 369.34% |
20 Years2006-09-14 | $ 23.37 | 21x |
30 Years1996-09-13 | $ 10.50 | 48x |
All Time1991-06-21 | $ 0.95 | 539x |
| Period | Last Price2026-09-14 | 1 Year2025-09-12 | 5 Years2021-09-14 | 10 Years2016-09-14 | 20 Years2006-09-14 | 30 Years1996-09-13 | All Time1991-06-21 |
|---|---|---|---|---|---|---|---|
| Price | $ 509.56 | $ 641.14 | $ 661.39 | $ 108.57 | $ 23.37 | $ 10.50 | $ 0.95 |
| Return | — | -20.52% | -22.96% | 369.34% | 21x | 48x | 539x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 4.55B | $ 1.13B | $ 196M |
| 2025 | $ 4.30B | $ 1.05B | $ 180M |
| 2024 | $ 3.89B | $ 887M | $ 288M |
| 2023 | $ 3.66B | $ 845M | $ 453M |
| 2022 | $ 3.36B | $ 679M | $ 112M |
| 2021 | $ 3.21B | $ 744M | $ 144M |
| 2020 | $ 2.70B | $ 581M | $ 383M |
| 2019 | $ 2.40B | $ 427M | $ 90M |
| 2018 | $ 2.21B | $ 377M | $ 123M |
| 2017 | $ 1.96B | $ 263M | $ 471M |
| 2016 | $ 1.77B | $ 222M | $ 391M |
| 2015 | $ 1.60B | $ 192M | $ 342M |
| 2014 | $ 1.48B | $ 181M | $ 322M |
| 2013 | $ 1.37B | $ 187M | $ 279M |
| 2012 | $ 1.29B | $ 178M | $ 223M |
| 2011 | $ 1.21B | $ 161M | $ 183M |
| 2010 | $ 1.10B | $ 141M | $ 156M |
| 2009 | $ 1.03B | $ 122M | $ 106M |
| 2008 | $ 1.02B | $ 116M | $ 78M |
| 2007 | $ 922M | $ 94M | $ 60M |
| 2006 | $ 739M | $ 93M | $ 96M |
| 2005 | $ 638M | $ 78M | $ 132M |
| 2004 | $ 549M | $ 78M | $ 137M |
| 2003 | $ 475M | $ 57M | $ 220M |
| 2002 | $ 412M | $ 45M | $ 147M |
| 2001 | $ 386M | $ 37M | $ 79M |
| 2000 | $ 367M | $ 36M | $ 75M |
| 1999 | $ 356M | $ 32M | $ 58M |
| 1998 | $ 319M | -$ 15M | $ 109M |
| 1997 | $ 263M | -$ 21M | $ 107M |
| 1996 | $ 267M | $ 32M | $ 127M |
| 1995 | $ 188M | $ 21M | $ 149M |
| 1994 | $ 126M | $ 13M | $ 25M |
| 1993 | $ 93M | $ 9M | $ 18M |
| 1992 | $ 57M | $ 4M | $ 17M |
| IPO1991 | $ 30M | $ 3M | $ 9M |
IDEXX Laboratories Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 638M to $ 4.30B and net income grew from $ 78M to $ 1.05B. Revenue increased in every one of those 20 years; net income in 18.
Across IDEXX Laboratories Inc's full reported history, from 1991 to 2025, revenue grew from $ 30M to $ 4.30B and net income grew from $ 3M to $ 1.05B. Revenue increased in 97% of the years measured; net income in 89%.
IDEXX Laboratories Inc currently holds a 20-year HDB Score of 9.1 out of 10. How the HDB Score is calculated.
Membership
Continue IDXX’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,827 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
